Institution · BrightPath Biotherapeutics (Japan)

Most cited papers from BrightPath Biotherapeutics (Japan)

BrightPath Biotherapeutics (Japan)

What are the most cited papers from BrightPath Biotherapeutics (Japan)?

The most cited paper from BrightPath Biotherapeutics (Japan) is "Phase Ib/II Study of Pembrolizumab and Pegylated-Interferon Alfa-2b in Advanced Melanoma" (Diwakar Davar, Hong Wang, Joë-Marc Chauvin et al., 2018), with 85 citations. Next come "Autologous antigen-presenting cells efficiently expand piggyBac transposon CAR-T cells with predominant memory phenotype" (33) and "Generation of GM-CSF-producing antigen-presenting cells that induce a cytotoxic T cell-mediated antitumor response" (28).

Published FieldAccess

Showing 9 of 9 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Phase Ib/II Study of Pembrolizumab and Pegylated-Interferon Alfa-2b in Advanced Melanoma Diwakar Davar, Hong Wang, Joë-Marc Chauvin et al. · Journal of Clinical Oncology Open access	25 Oct 2018	85
2	Autologous antigen-presenting cells efficiently expand piggyBac transposon CAR-T cells with predominant memory phenotype Kayoko Nakamura, Shigeki Yagyu, Shogo Hirota et al. · Molecular Therapy — Methods & Clinical Development Open access	23 Mar 2021	33
3	Generation of GM-CSF-producing antigen-presenting cells that induce a cytotoxic T cell-mediated antitumor response Hiroaki Mashima, Rong Zhang, Tsuyoshi Kobayashi et al. · OncoImmunology Open access	2020	28
4	Identification of Novel HLA Class II-Restricted Neoantigens Derived from Driver Mutations Susumu Iiizumi, Junya Ohtake, Naoko Murakami et al. · Cancers Open access	24 Feb 2019	28
5	Enhancing Mass spectrometry-based tumor immunopeptide identification: machine learning filter leveraging HLA binding affinity, aliphatic index and retention time deviation Feifei Wei, Taku Kouro, Yuko Nakamura et al. · Computational and Structural Biotechnology Journal Open access	3 Feb 2024	18
6	Development of antigen‐prediction algorithm for personalized neoantigen vaccine using human leukocyte antigen transgenic mouse Jimmy Charneau, Toshihiro Suzuki, Manami Shimomura et al. · Cancer Science Open access	5 Feb 2022	10
7	The importance of specific citrullinated clusterin and vimentin found in a multi-coloured bead-based citrulline-peptide array system in rheumatoid arthritis Yuri Yoshizawa, Toru Nakao, Katsuki Tsuritani et al. · Clinical and Experimental Rheumatology Open access	24 Dec 2020	6
8	1005P A new platform of personalized neoantigen cancer vaccines directed by checkpoint inhibitor antibodies to improve cancer immunity Yuta Mishima, Fumiko Isoda, Norihito Matsumoto et al. · Annals of Oncology Open access	Sep 2021	1
9	987P A new therapeutic antibody against CD73 that ameliorates the tumor microenvironment and improves the efficacy of cancer immunotherapy Toshifumi Obonai, Hyun Seung Ban, Yuko Mishima et al. · Annals of Oncology Open access	Sep 2021	0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.